PACTR201407000856135已完成未知
Effect of fenofibrate alone and in combination on serum sirtuin 1 and fetuin A levels
faculty of pharmacy, ain shams university0 个研究点目标入组 60 人开始时间: 2014年7月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50 Year(s) 至 90 Year(s)（—）
- 性别
- Female
入选标准
- •Subjects suffering from type 2 DM for at least 5 years and body mass index (BMI) > 30 for diabetic patients groups, Over 50 years of age for females, No definite indication for receiving, and no contraindication to receiving fenofibrate (and pioglitazone for Group 2) in addition to their existing therapy.
排除标准
- •Subjects with type 1 diabetes, Allergy to any fibrate drugs, Allergy or contraindication for pioglitazone drug (for Group 2), History of pancreatitis or pulmonary embolism or deep venous thrombosis, Use of any other investigational agents in last 8 weeks, Unstable condition including recent MI, heart failure, prior organ transplant, severe renal or liver dysfunction, history of myositis or untreated hypothyroidism, Pregnancy and lactation.
研究者
相似试验
已完成
4 期
A CLINICAL TRIAL ON EFFECT OF SINGLE DOSE FENOFIBRATE AS AN ADJUNCT TO PHOTOTHERAPY IN NEONATAL JAUNDICECTRI/2023/03/050811Deepaa S94
已完成
3 期
Fenofibrate in PSCIRCT20200427047225N1Shahid Beheshti University of Medical Sciences30
已完成
不适用
Comparison of therapeutic effects of Fenofibrate and Gemfibrozil on Lipid in patients with DiabetesIRCT201401096710N4Research deputy of Tabriz University of Medical Sciences60
已完成
3 期
Comparison between the Effect of Fenofibrate and Clofibrate on Term Neonates with Hyperbilirubinemiaeonatal jaundice.Neonatal jaundice from other and unspecified causesIRCT20190708044158N1Babol University of Medical Sciences80
招募中
3 期
The effect of fenofibrate on the prevention of neonatal hyperbilirubinemia in mothers with O type blood groupIRCT20200822048473N1Babol University of Medical Sciences120